Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin in non-ST-elevation myocardial infarction
IRCT20220516054874N2Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in myocardial infarction (MI) comparing Gabapentin plus common treatment with Placebo plus common treatment (2 arms). Primary endpoint: Change in hs-CRP level. Started Jul 2022; status: completed.
02
Drugs
gabapentin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on IRCT20220516054874N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220516054874N2.